When Capital Heals and Harms, India’s Private Equity Healthcare Dilemma
After the pandemic receded, India stood at a critical inflection point in healthcare. The crisis had exposed gaping holes in public health infrastructure, overwhelmed existing facilities, and left millions without access to timely care. The need of the hour was clear: facility modernisation, specialisation expansion, and systemic upgradation. Into this breach stepped private equity (PE). Between 2022 and 2024, approximately ₹30 billion was invested by PE firms into India’s healthcare sector. Today, PE-owned entities own more than 50 per cent of India’s top hospitals.
This is not anomalous. The model has been successful abroad. In the United States, for instance, some 488 hospitals are owned by PE firms, representing 8.5 per cent of private hospitals. But with capital come costs: elevated hospital expenditure, insurance premium inflation, and accessibility challenges for many patients. And without sufficient government subsidies, alternative and quality public facilities, and an active litigation framework akin to that in the US — which can keep predatory pricing in check while exacting draconian penalties for misdiagnoses, negligence, malpractice, and overselling — these issues become structural rather than incidental.
Does India have the regulatory will and policy architecture to ensure that investor returns and patient-first outcomes grow in tandem? This article examines the dual nature of PE ownership in Indian healthcare: the undeniable efficiency gains and expansion, and the troubling rise in costs, insurance premiums, and out-of-pocket expenses. It concludes that PE involvement can be part of the solution — but only if coupled with policy frameworks that enforce price transparency, timely reimbursements, and patient rights.
Part I: The Efficiency Argument – What PE Has Brought to Indian Healthcare
There is no doubt that PE-backed hospital chains have raised the bar on operational excellence. By consolidating fragmented networks of clinics, driving high-margin specialty hospitals (cardiac, cancer, fertility units), and accelerating digital and technological solutions like diagnostics and telemedicine, these entities have introduced efficiencies that were previously absent in India’s largely unorganised healthcare landscape.
Diagnostic turnaround times have compressed significantly in tech-enabled PE-owned facilities. What once took days now takes hours. Electronic medical records (EMRs) , largely absent in standalone hospitals a decade ago, are now par for the course. Standardised protocols, centralised procurement, and data-driven management have reduced waste and improved outcomes.
In the wake of efficiency comes expansion. Major hospital chains have announced ambitious bed addition targets. Max Healthcare plans to add 10,000 beds by 2027. Apollo Hospitals, with a 43.5 per cent FII stake (versus the promoter-family share of 29 per cent), has targeted 4,300 new beds in the same period. These are not marginal increases; they represent a significant expansion of India’s private hospital capacity.
For a country with 1.4 billion people and a chronic shortage of hospital beds (India has approximately 1.4 beds per 1,000 population, far below the WHO recommendation of 3-5 beds), this expansion is desperately needed. The question is not whether PE investment can build capacity — it clearly can. The question is: at what cost, and for whom?
Part II: The Cost Conundrum – Rising Premiums and Out-of-Pocket Expenses
The dark side of PE ownership is equally clear. Expansion targets and high internal rates of return (typically 18-25 per cent) push hospitals to maximise revenues and margins. This has exacerbated medical inflation. The cost of surgeries has spiked 50-70 per cent since 2020. Insurance premiums have risen correspondingly — by 10-15 per cent in 2025 alone, according to the article, owing to higher claims costs. As a result, Indians are paying 25 per cent higher premiums for health insurance.
Out-of-pocket expenses (OOPE) now account for 39 per cent of all health expenditure in India. This is a staggering figure. It means that even when people have insurance, they are still paying nearly two-fifths of their healthcare costs directly. For the poor, that is catastrophic. For the middle class, it is draining. For the insured, it is a betrayal of the promise of coverage.
How does PE ownership drive these cost increases? The article identifies several mechanisms:
First, consolidation concentration. Large hospital chains, through their market power, can dictate terms to insurers. When a handful of chains control most of the beds in a city, insurers have no bargaining power. They cannot refuse to include these hospitals in their networks, because patients will not buy insurance that excludes the only available facilities. The hospitals, therefore, have no incentive to reduce patient charges.
Second, emphasis on profitability. Hospital chains prioritise high-margin specialties — cardiac surgery, cancer treatment, orthopaedics, fertility — over general medicine. These specialties generate higher average revenue per bed. But they also limit access for routine care. A patient with a chronic condition like diabetes or hypertension, who needs regular check-ups and medication, may find that the nearest PE-owned hospital has no general medicine OPD — only expensive specialty clinics.
Third, upselling and package unbundling. To improve margins, hospitals add extra diagnostic tests and non-essential services to bills. A surgery that was quoted at ₹1.5 lakh might end up costing ₹2.5 lakh once “pre-operative tests,” “consumables,” “theatre charges,” and “doctor fees” are added separately. This practice, known as unbundling, makes it impossible for patients to compare prices or make informed choices.
Fourth, rising insurance premiums. When hospital charges rise, insurers raise premiums or restrict coverage. This shifts the burden to patients via co-payments (where the patient pays a percentage of the bill) or premium hikes. The cycle is self-reinforcing: higher hospital costs → higher insurance premiums → higher out-of-pocket expenses → more people avoiding care.
Fifth, urban market concentration. PE-backed chains typically cater to big cities — Delhi, Mumbai, Bengaluru, Chennai, Hyderabad. Unlike in the US, where 27 per cent of PE-owned hospitals serve rural populations, Indian PE-owned hospitals are overwhelmingly urban. This means that the rural poor, who need affordable care the most, have the least access to the facilities built with PE capital.
Part III: The Regulatory Deficit – What India Lacks That the US Has
The United States, for all its own healthcare problems, has a litigation framework that can, at least in theory, keep predatory pricing in check. Medical malpractice lawsuits, class-action suits against hospital chains, and regulatory actions by bodies like the Centers for Medicare & Medicaid Services (CMS) impose real costs on hospitals that engage in abusive practices. Draconian penalties for misdiagnoses, negligence, malpractice, and overselling are possible.
India has nothing comparable. Medical litigation is slow, expensive, and uncertain. The Consumer Protection Act provides a mechanism for patients to file complaints, but the process is lengthy, and the compensation awards are modest. The National Medical Commission (NMC) has disciplinary powers, but it is understaffed and overburdened. No dedicated health regulator exists with the authority to audit hospital pricing, handle patient grievances, or award meaningful penalties.
Without such a regulatory backstop, the profit-maximising incentives of PE ownership operate without effective constraint. Hospitals can raise prices, unbundle packages, and upsell tests because they know that the chances of being held accountable are minimal.
Part IV: The Path Forward – Six Safeguards for Patient-First Outcomes
The article proposes six concrete measures to ensure that PE investment benefits patients as well as investors:
1. Transparent billing through standardised price lists. Hospitals should be required to publish standardised price lists for common procedures (e.g., normal delivery, C-section, appendectomy, angioplasty, knee replacement). These lists should be easily accessible online and in hospital lobbies. This would prevent arbitrary markups and communicate clearer expectations to patients.
2. Tiered pricing and referral incentives. Hospitals should be required to reserve a fixed share of beds for low-income patients at regulated rates, cross-subsidised by premium services. This model — common in many countries with mixed public-private systems — ensures that the poor are not excluded from the benefits of private investment.
3. Outcome-based contracts. Insurers and hospitals should move away from fee-for-service reimbursement (where hospitals are paid for each procedure) toward outcome-based contracts (where hospitals are reimbursed based on quality and outcome metrics). This would discourage unnecessary services and reward efficiency.
4. Regulatory empowerment. The Insurance Regulatory and Development Authority of India (IRDAI) should be strengthened, or a dedicated health regulator created, with the authority to audit hospital pricing, handle patient grievances, and award penalties for violations. This regulator should have teeth — the power to impose fines, suspend licenses, and refer cases for criminal prosecution.
5. Primary care investment. PE firms should be encouraged (through tax incentives or public-private partnership models) to invest in primary care and preventive health services. This would alleviate the need for expensive hospital services, reduce overall system costs, and create a pipeline of patients for specialty care.
6. Faster claims settlements. Payment rules should encourage or mandate settlement within agreed-upon timelines. Automated clearing facilities could ensure that hospitals get paid on time without resorting to aggressive collection practices against patients.
Part V: The Long-Term Horizon – From Quick Returns to Sustainable Infrastructure
One of the fundamental mismatches in the current model is between the time horizon of PE investors (typically 5-7 years, seeking 18-25 per cent internal rates of return) and the time horizon of healthcare infrastructure (which requires decades of sustained investment). Hospitals are not software startups. They are capital-intensive, slow-to-mature assets that serve communities for generations.
Promoting longer investment timelines would be compatible with infrastructure building. If PE firms were incentivised to hold investments for 10-15 years rather than 5-7, they would be less pressured to maximise short-term margins and more able to invest in quality, staff training, and community outreach. This could be achieved through tax incentives for long-term holdings or through the structure of PE funds themselves.
Part VI: The Global Context – Falling Rupee and Global Uncertainty
The article adds a sobering note: with global uncertainty and a falling rupee, the healthcare cost situation will only deteriorate. A weaker rupee makes imported medical equipment, pharmaceuticals, and consumables more expensive. These costs are passed on to patients. Global economic turmoil may also deter new PE investment, limiting the expansion that India desperately needs.
In this context, the choice is not between PE ownership and no PE ownership. The capital is already in the system. More than 50 per cent of India’s top hospitals are PE-owned. The question is how to regulate that ownership to align investor incentives with patient outcomes.
Conclusion: Quality Healthcare Is Not a Luxury Good
Quality healthcare should be a premium service valued by the majority, not an exclusive privilege monopolised by the price-agnostic. The influx of PE capital into Indian healthcare has brought undeniable benefits: efficiency, technology, expansion, and scale. But it has also brought rising costs, inflated insurance premiums, and catastrophic out-of-pocket expenses for millions.
The solution is not to demonise PE investment — that horse has left the barn. The solution is to build a regulatory architecture that ensures patient-first outcomes without strangling the capital that the system needs. Transparent billing, tiered pricing, outcome-based contracts, regulatory empowerment, primary care investment, and faster claims settlements are not radical ideas. They are standard practices in well-regulated healthcare systems around the world.
India’s healthcare system stands at an inflection point. The decisions made today — about price transparency, about patient rights, about the balance between investor returns and public health — will determine whether the next decade brings affordable, accessible, high-quality care for all, or a two-tier system where the rich get world-class treatment and the poor get catastrophic bills.
Healthcare isn’t a luxury good. It’s time for policy to catch up with that truth.
5 Questions & Answers Based on the Article
Q1. How much PE investment flowed into Indian healthcare between 2022 and 2024, and what share of top hospitals are now PE-owned?
A1. Between 2022 and 2024, approximately ₹30 billion was invested by private equity firms in India’s healthcare sector. Today, PE-owned entities own more than 50 per cent of India’s top hospitals. The article notes that this model is not anomalous, as seen in the US where 488 hospitals (8.5 per cent of private hospitals) are PE-owned.
Q2. What are the main efficiency gains that PE investment has brought to Indian healthcare?
A2. The main efficiency gains include: (1) consolidation of fragmented clinic networks, (2) driving high-margin specialty hospitals (cardiac, cancer, fertility units), (3) accelerating digital and technological solutions like diagnostics and telemedicine, (4) significantly compressed diagnostic turnaround times, and (5) widespread adoption of electronic medical records (EMRs) , which were largely absent in standalone hospitals a decade ago. Additionally, major chains like Max Healthcare and Apollo have announced ambitious bed expansion plans.
Q3. According to the article, by how much have surgery costs, insurance premiums, and out-of-pocket expenses increased under PE-dominated healthcare?
A3. The article cites: (1) land deal cost of surgeries has spiked 50-70 per cent since 2020; (2) insurance premiums rose by 10-15 per cent in 2025 due to higher claims costs, resulting in Indians paying 25 per cent higher premiums; and (3) out-of-pocket expenses now account for 39 per cent of all health expenditure in India. This means that even with insurance, patients are still paying nearly two-fifths of their healthcare costs directly.
Q4. What are the five mechanisms through which PE ownership drives cost increases, according to the article?
A4. The five mechanisms are: (1) Consolidation concentration – large hospital chains dictate terms to insurers, obviating the need to reduce patient charges. (2) Emphasis on profitability – chains prioritise high-margin specialties over general medicine, increasing revenue per bed while limiting routine care access. (3) Upselling and package unbundling – hospitals add extra diagnostic tests and non-essential services to bills, inflating costs. (4) Rising insurance premiums – higher hospital charges lead insurers to raise premiums or restrict coverage, shifting burden to patients. (5) Urban market concentration – unlike in the US (where 27 per cent serve rural areas), Indian PE-owned chains cater overwhelmingly to big cities, excluding rural populations.
Q5. What six safeguards does the article propose to ensure patient-first outcomes alongside PE investment?
A5. The six proposed safeguards are: (1) Transparent billing through standardised price lists for common procedures to prevent arbitrary markups. (2) Tiered pricing/referral incentives – reserve a fixed share of beds for low-income patients at regulated rates, cross-subsidised by premium services. (3) Outcome-based contracts – reimburse hospitals based on quality and outcome metrics rather than procedure count. (4) Regulatory empowerment – strengthen IRDAI or create a dedicated health regulator to audit pricing, handle grievances, and award penalties. (5) Primary care investment – encourage PEs to fund primary and preventive care through insurance-linked models or PPPs. (6) Faster claims settlements – enforce payment timelines or use automated clearing facilities to ensure timely payment. The article also suggests promoting longer investment horizons (10-15 years rather than 5-7) to reduce pressure for short-term margin maximisation.
